Zyban, Wellbutrin, Bupropion
Zyban, Wellbutrin, Bupropion Newswire

Zyban, Wellbutrin, Bupropion Newswire

Comprehensive Real-Time News Feed for Zyban, Wellbutrin, Bupropion (generic).

Results 1 - 20 of 86 in Zyban, Wellbutrin, Bupropion (generic)

  1. The New Obesity Drugs: an Rx for Weight Loss?Read the original story

    Wednesday Aug 26 | US News & World Report

    Drugs that assist with weight loss are designed to target parts of the brain involved with appetite and satiety, and interfere with hunger signals. People who need to lose a significant amount of weight - and there are a lot of them - finally have more medical options.

    Comment?

  2. So I am 3 1/2 years into being a non smoker.Read the original story w/Photo

    Sunday Aug 23 | Geekzone

    Champix worked great for us an I could not believe the absence of craving while using it. Used an app to track how we have been going, example below.

    Comment?

  3. Chantix Smoking Cessation Drug Is Not Helping Smokers QuitRead the original story

    Friday Aug 21 | Scientific Blogging

    The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a new study in Tobacco Control which suggests that the primary effect of varenicline has only been to displace the use of older tobacco addiction therapies, such as nicotine patches and the antidepressant, bupropion . Moreover, in this population analysis, researchers said varenicline's enhanced effectiveness in helping smokers quit, compared with other cessation aides, appeared to be short-lived, lasting for three months, after which time varenicline users no longer had higher rates of success.

    Comment?

  4. UK study: E-cigarettes are 95% safer than smoking and could help many quitRead the original story w/Photo

    Friday Aug 21 | Examiner.com

    E-cigarettes got a virtually spotless bill of health Wednesday in a UK research study, which found that e-cigarette use, or " vaping ," is approximately 95% less harmful than tobacco smoking . In addition, the study found that vaping can help people quit altogether, that it poses negligible risk to others through passive inhalation, and that e-cigarettes are not contributing to increased smoking by young people.

    Comment?

  5. It won't solve America's tobacco epidemicRead the original story

    Tuesday Aug 18 | San Diego Reader

    A heavily advertised smoking-cessation drug that's been on the market since 2006 has no discernible effect on decreasing cigarette use among adults, researchers at the UC San Diego School of Medicine are reporting. The main effect of varenicline, popularly known under its marketing name of Chantix, has been to displace other smoking-cessation drugs such as nicotine patches and the antidepressant marketed under the name Zyban, according to a study published August 17 in the online edition of Tobacco Control .

    Comment?

  6. Smoking cessation drug not boosting number of smokers who quitRead the original story w/Photo

    Tuesday Aug 18 | Medical News Today

    The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking , according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control , suggest that the primary effect of varenicline has been to displace the use of older tobacco addiction therapies, such as nicotine patches and the antidepressant , bupropion .

    Comment?

  7. Why drug to quit smoking may not work wondersRead the original story

    Tuesday Aug 18 | Newkerala.com

    Even a drug that helps people kick the butt may not increase the number of those who do so, says a new study which suggests that inspiring smokers to quit is as important as aids that enable them do so. The study found that introduction of a new prescription smoking-cessation drug varenicline in 2006 has had no significant impact on the rate at which US adults successfully quit smoking.

    Comment?

  8. New prescription smoking-cessation drug not helping smokers quitRead the original story w/Photo

    Tuesday Aug 18 | Medical News

    The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control , suggest that the primary effect of varenicline has been to displace the use of older tobacco addiction therapies, such as nicotine patches and the antidepressant, bupropion .

    Comment?

  9. Sexual Dysfunction in Women: A Practical ApproachRead the original story

    Thursday Aug 13 | American Academy of Family Physicians

    Sexual dysfunction in women is a common and often distressing problem that has a negative impact on quality of life and medication compliance. The problem is often multifactorial, necessitating a multidisciplinary evaluation and treatment approach that addresses biological, psychological, sociocultural, and relational factors.

    Comment?

  10. Orexigen Announces Korean Distributorship Agreement with Kwang Dong PharmaceuticalRead the original story

    Wednesday Aug 5 | BioSpace

    Under the terms of the agreement, will be responsible for seeking regulatory approval and for all commercialization activity and expenses. Orexigen will supply Contrave tablets to established relationships with obesity societies and opinion leaders as well as their strong consumer marketing capabilities make them an ideal partner for Contrave in Korea," said , CEO of Orexigen.

    Comment?

  11. Orexigen And Takeda Announce An Amended And Restated Collaboration AgreementRead the original story

    Wednesday Aug 5 | BioSpace

    "CONTRAVE has quickly established itself as the most prescribed branded weight-loss medication in a rapidly growing market. Today, we have reaffirmed our commitment to the success of CONTRAVE in "Takeda's market-leading share of voice through the sales organization, combined with the partnership's commitment to patient support, has enabled a strong launch and early results for CONTRAVE," said , CEO of Orexigen.

    Comment?

  12. Job-hunting? GSK looking for 140 staff at NC plantRead the original story w/Photo

    Thursday Aug 6 | In-PharmaTechnologist.com

    A spokesperson told in-Pharmatechnologist.com the facility in Zebulon, NC is adding another assembly line for production of Advair and Ellipta dry powder inhalers and other respiratory drugs Breo, Anoro, and Incruse. It will take on 100 employees this year , and another 30 to 40 in 2016.

    Comment?

  13. Bupropion Hydrochloride 24 hour ER TabletsRead the original story

    Wednesday Aug 5 | ASHP

    Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT. This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use.

    Comment?

  14. Health-care interventions to promote and assist tobacco cessation: a...Read the original story

    Wednesday Aug 5 | CiteULike

    Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development Aims This paper provides a concise review of the efficacy, effectiveness and affordability of health-care interventions to promote and assist tobacco cessation, in order to inform national guideline development and assist countries in planning their provision of tobacco cessation support. Methods Cochrane reviews of randomized controlled trials of major health-care tobacco cessation interventions were used to derive efficacy estimates in terms of percentage-point increases relative to comparison conditions in 6-12-month continuous abstinence rates.

    Comment?

  15. To quit those cigarettes, use more than one toolRead the original story

    Jul 23, 2015 | Cortez Journal News

    Among people younger than 18, the U.S. Public Health Service predicts another 5.4 million smoking-related deaths.

    Comment?

  16. Smoking Cessation and Nicotine De-addiction Products Market Estimated to Value USD 16.02 Billion GloRead the original story

    Jul 15, 2015 | Digital Pro Sound

    SUBJECT: Smoking Cessation and Nicotine De-addiction Products Market Estimated to Value USD 16.02 Billion Glo KEYWORDS: Smoking Cessation and Nicotine De-addiction Products Market According to the report "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" ,the global market for Smoking Cessation and Nicotine De-addiction Products is estimated to grow at the rate of CAGR 8.7% in the forecasted period of 2013 to 2019 and reach a value of USD 16.02billion in 2019. This market was valued at USD 5.1 billion in 2012.

    Comment?

  17. Smoking cessation drug linked to birth defects when taken during pregnancyRead the original story

    Jul 7, 2015 | PR Log

    Research has linked Zyban to an increased risk of life-threatening, congenital, cardiac birth defects in babies born to mothers who took the drug during pregnancy. Zyban is marketed as a prescription smoking cessation drug.

    Comment?

  18. B.C. smoking cessation program, Pfizer's Champix drug facing questionsRead the original story w/Photo

    Jul 3, 2015 | CBC News

    Questions are being raised about the research the fired B.C. health workers were involved in, including Christy Clark's highly-touted smoking cessation program and a controversial drug named Champix. Questions are being raised about the research two of the fired B.C. health workers were involved in, including Christy Clark's highly-touted smoking cessation program and a controversial drug named Champix.

    Comment?

  19. Joni Mitchell's Aneurysm, ExplainedRead the original story w/Photo

    Jun 30, 2015 | Switched

    JANUARY 25: Recording artist Joni Mitchell attends the 56th annual GRAMMY Awards Pre-GRAMMY Gala and Salute to Industry Icons honoring Lucian Grainge at The Beverly Hilton on January 25, 2014 in Beverly Hills, California. Musician Joni Mitchell is recovering from an aneurysm she suffered in March, according to a statement from her conservator, Leslie Morris.

    Comment?

  20. Men urged to pay more attention to their healthRead the original story w/Photo

    Jun 15, 2015 | Malvern Gazette

    LOOKING after your health and wellbeing is important for everyone, from eating healthily and getting enough exercise to making sure that you're taking care of your mental wellbeing. But as statistics show it's especially important for men, as they are far more likely to lead an unhealthy lifestyle.

    Comment?